Innovent’s IBI363 Gets 2nd NMPA Breakthrough for Lung Cancer
June 5, 2025
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology, and other